Projects per year
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Institute for Advancing Translational Medicine in Bone and Joint Diseases is active. Topic labels come from the works of this unit's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The role of the interactions between N domain and Linker 2 of DKK1 in modulating the immunosuppressive tumor microenvironment mediated by DKK1 C domain
YU, Y. (PI) & Li, P. (CoI)
1/01/23 → 30/06/25
Project: Research project
Research Output
-
Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release
Ma, Y., Xie, D., Chen, Z., Shen, X., Wu, X., Ding, F., Ding, S., Pan, Y., Li, F., Lu, A. & Zhang, G., 1 Jul 2024, In: Journal of Translational Medicine. 22, 1, 13 p., 604.Research output: Contribution to journal › Journal article › peer-review
Open Access1 Citation (Scopus) -
Aptamer Functionalized Hypoxia-potentiating Agent and Hypoxia-inducible Factor Inhibitor Combined with Hypoxia-activated Prodrug for Enhanced Tumor Therapy
Ma, Y., Zhang, H., Shen, X., Yang, X., Deng, Y., Tian, Y., Chen, Z., Pan, Y., Luo, H., Zhong, C., Yu, S., Lu, A., Zhang, B., Tang, T. & Zhang, G., 28 Aug 2024, In: Cancer Letters. 598, 12 p., 217102.Research output: Contribution to journal › Journal article › peer-review
Open Access2 Citations (Scopus) -
Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer
Chen, Y., Yang, J., Wang, C., Wang, T., Zeng, Y., Li, X., Zuo, Y., Chen, H., Zhang, C., Cao, Y., Sun, C., Wang, M., Cao, X., Ge, X., Liu, Y., Zhang, G., Deng, Y., Peng, C., Lu, A. & Lu, J., 25 Jul 2024, In: Journal of Experimental and Clinical Cancer Research. 43, 1, 18 p., 207.Research output: Contribution to journal › Journal article › peer-review
Open Access2 Citations (Scopus)
Activities
-
Frontiers in Molecular Biosciences (Journal)
LIU, J. (Guest editor)
9 Mar 2023 → 14 Oct 2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Chinese Journal of Natural Medicines (Journal)
LIU, J. (Reviewer)
8 Mar 2023 → 2 Jun 2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Journal of Orthopaedic Translation (Journal)
LIU, J. (Reviewer)
8 May 2023 → 6 Jun 2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)